Argenx premieres a mystery to me, a docuseries inspired by the myasthenia gravis patient experience

Breda, the netherlands and ghent, belgium, nov. 17, 2020 /prnewswire/ -- argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced the release of a new docuseries, a...
ARGX Ratings Summary
ARGX Quant Ranking